Standard vs. Shorter Filter Life in Critical Kidney Support
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares two different timeframes for changing filters during a critical kidney support treatment (CRRT) used when kidneys suddenly fail in hospitalized patients. The goal is to understand which filter-change schedule works better and reduces complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the ICU (intensive care unit) with severe, sudden kidney failure that requires continuous kidney-support treatment
- You have not had long-term kidney disease or been on dialysis before this hospital admission
- You do not have an active do-not-resuscitate order
- You are willing to provide informed consent (you or a legal representative can sign)
- You are not currently in another study that affects your immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
This trial tests a special device that filters parts of the blood to calm inflammation in people with severe acute kidney injury in the ICU. It may help improve recovery and reduce complications by “deactivating” certain immune cells.
This study compares two different doses of continuous kidney replacement therapy (CRRT, a type of dialysis) for patients in the intensive care unit with acute kidney injury. It aims to find out if a lower dose is as safe and effective as the standard dose.
This trial compares two types of dialysis (hemodialysis and hemodiafiltration) to see which is better at removing waste from the blood in ICU patients with sudden kidney failure. It may help doctors choose the best treatment for you.
This trial studies whether a blood test called delta C-cistatin can help doctors predict when patients can safely stop continuous kidney dialysis after acute kidney injury.
This study looks at two different blood thinners—regional citrate and systemic heparin—used during continuous kidney replacement therapy (CKRT) for acute kidney injury (AKI). It aims to learn which works better and safer.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.